A new study evaluating the quadratic phenotypic optimization platform shows it can accurately predict personalized drug ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.

Interesting trends were observed in the subgroup analyses of the phase 3 uproleselan study in relapsed or refractory acute ...

However, treating patients with bendamustine/rituximab plus acalabrutinib might be preferred to either option with cytarabine. Although the results showed that the bendamustine/rituximab plus ...

Martin Dreyling, MD, University Hospital LMU Munich, in Germany, discusses the final follow-up results of the TRIANGLE study ...

Venetoclax is under clinical development by AbbVie and currently in Phase II for Relapsed Acute Myeloid Leukemia.

Patients will be randomized 2:2:1 into three treatment arms. In Arms A and B, patients will receive Vanflyta or placebo, respectively, in combination with cytarabine and anthracycline induction and ...

Dose-finding clinical trial in China designed to evaluate safetyand preliminary anti-tumor activity of SN301A (SENTI-301A manufactured in ...

INR:6711. kerala football team vs meghalaya football team standings The price of cytarabine has increased by 120%, and t ...

INR:7553. freshnet farms private limited The new version of the medical insurance catalogue implements three PD-1 products, and the prices are expo ...

Gamezy slte College Brawl AbbVie's Phase III study of Venclexta + cytarabine as first-line treatment did not reach the primary endpoint Nation ...